Results 31 to 40 of about 16,602 (194)

Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study

European Radiology Experimental, 2021
Background No chemotherapeutic agents have been standardised for transarterial chemoembolisation (TACE). In particular, doxorubicin has no defined optimal dosage in TACE procedures.
Ahmed A. Bessar, Ahmed Farag, Sameh M. Abdel Monem, Fady M. Wadea, Shady E. Shaker, Mahmoud Ahmed Ebada, Manar A. Bessar   +6 more
doaj   +1 more source

Gallbladder Perforation after Transarterial Chemoembolization in a Patient with a Huge Hepatocellular Carcinoma

The Korean Journal of Gastroenterology, 2020
Transarterial chemoembolization (TACE) is a common treatment for unresectable hepatocellular carcinoma (HCC). The most common complications after TACE are non-specific symptoms called post-embolization syndrome, such as abdominal pain or fever.
Min Young Son, Byung Hoon Han, Sang Uk Lee, Byung Cheol Yun, yung Cheol Yun, Jin Do Huh   +5 more
doaj   +1 more source

Balloon-occluded transarterial chemoembolization for hepatocellular carcinoma: History, background, and the roles

International Journal of Gastrointestinal Intervention, 2020
Super-selective lipiodol balloon-occluded transarterial chemoembolization (SSLB-TACE) increases lipiodol accumulation in the targeted nodule. To understand the mechanism of increased accumulation, it is necessary to understand intra-hepatic collateral ...
Toshiyuki Irie, Nobuyuki Takahashi, Sodai Hoshiai   +2 more
doaj   +1 more source

Rupture of hepatocellular carcinoma after transcatheter arterial chemoembolization: A case report

International Journal of Gastrointestinal Intervention, 2021
Transcatheter arterial chemoembolization (TACE) is one of the most common treatment options for patients with unresectable hepatocellular carcinoma (HCC). HCC rupture following TACE is a rare but potentially life-threatening complication.
Hye Hyeon Moon, Hee Ho Chu, Ji Hoon Shin
doaj   +1 more source

Improved clinical outcome using transarterial chemoembolization combined with radiofrequency ablation for patients in Barcelona clinic liver cancer stage A or B hepatocellular carcinoma regardless of tumor size: results of a single-center retrospective case control study

BMC Cancer, 2019
Background To determine the safety and efficacy of transarterial chemoembolization (TACE) combined with radiofrequency ablation (hereafter, TACE-RFA) in treating Barcelona Clinic Liver Cancer (BCLC) Stage A or B (hereafter, BCLC A/B) hepatocellular ...
Yanqiao Ren, Yanyan Cao, Hong Ma, Xuefeng Kan, Chen Zhou, Jiacheng Liu, Qin Shi, Gansheng Feng, Bin Xiong, Chuansheng Zheng   +9 more
doaj   +1 more source

Spectral CT in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma

Medicine, 2017
This study aimed to investigate the value of computed tomographic (CT) spectral imaging in evaluating the effect of transarterial chemoembolization (TACE).The records of 67 patients with hepatocellular carcinoma (HCC) who had undergone dynamic spectral CT before treatment were selected for the study.
Wang, Jun, Shen, Jia lin
openaire   +2 more sources

Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE

Open Life Sciences, 2018
Hepatocellular carcinoma is one of the leading causes of cancer-related death. Hepatic transcatheter arterial chemo-embolization (TACE) is commonly used clinically for advanced hepatocellular carcinoma treatment.
Wu Tao, Yao Yihui, Sun Ruimin, Wang Huili, Yin Xiaoxiang, Zhang Junna, Zhou Qing, Huangfu Chaoshen   +7 more
doaj   +1 more source

Intrahepatic portovenous shunt caused by ultraselective conventional transarterial chemoembolization for hepatocellular carcinoma: Report of two cases

International Journal of Gastrointestinal Intervention
We report two cases of intrahepatic portovenous shunt (IPVS) caused by conventional transarterial chemoembolization (cTACE) for hepatocellular carcinoma (HCC).
Shiro Miyayama, Masashi Yamashiro, Rie Ikeda, Takumi Sugiura, Seitaro Ishikawa, Naoko Sakuragawa   +5 more
doaj   +1 more source

Intraductal migration of necrotic hepatocellular carcinoma: A possible cause of obstructive cholangitis after chemoembolization

Gastrointestinal Intervention, 2018
Acute obstructive cholangitis due to the migration of necrotized tumor fragment(s) has been rarely reported after transarterial chemoembolization (TACE).
Hyo Jung Park, Ji Hoon Shin
doaj   +1 more source

Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma

World Journal of Gastroenterology, 2008
To prospectively assess the changes in parameters of computed tomography (CT) perfusion pre- and post-transarterial chemoembolization (TACE) of hepatocellular carcinoma (HCC) in different treatment response groups, and to correlate the changes with various responses of HCC to TACE.Thirty-nine HCC patients underwent CT perfusion examinations pre-(1 d ...
Guang, Chen, Da-Qing, Ma, Wen, He, Bao-Feng, Zhang, Li-Qin, Zhao   +4 more
openaire   +2 more sources